• Thumbnail for Exenatide
    Exenatide, sold under the brand name Byetta among others, is a medication used to treat type 2 diabetes. It is used together with diet, exercise, and...
    29 KB (2,668 words) - 00:13, 28 October 2024
  • Thumbnail for Tirzepatide
    K+ATP GLP-1 receptor agonists Albiglutide‡ Danuglipron† Dulaglutide Exenatide Liraglutide Lixisenatide Orforglipron§ Semaglutide Taspoglutide† DPP-4...
    44 KB (3,492 words) - 09:50, 22 October 2024
  • Thumbnail for Gila monster
    injection. Exenatide also slows the emptying of the stomach and causes a decrease in appetite, contributing to weight loss. The antidiabetic exenatide (Byetta)...
    47 KB (5,533 words) - 01:44, 18 October 2024
  • the exception of insulin, most GLP-1 receptor agonists (liraglutide, exenatide, and others), and pramlintide, all diabetes medications are administered...
    50 KB (5,222 words) - 13:28, 22 October 2024
  • Thumbnail for Amylin Pharmaceuticals
    produced three drugs: Symlin (pramlintide acetate), Byetta (exenatide) and Bydureon (exenatide extended release). In 1987, Amylin Pharmaceuticals was co-founded...
    14 KB (1,253 words) - 22:25, 14 August 2024
  • Thumbnail for Semaglutide
    suggested 1–3 years use of glucagon like peptide-1 receptor agonists like exenatide, liraglutide and dulaglutide may be linked with increased occurrence of...
    72 KB (6,068 words) - 00:10, 28 October 2024
  • Thumbnail for Reptile
    glucose; the substance is now synthesised for use in the anti-diabetes drug exenatide (Byetta). Another toxin from Gila monster saliva has been studied for...
    138 KB (14,853 words) - 00:57, 22 October 2024
  • Thumbnail for Lizard
    glucose; the substance is now synthesized for use in the anti-diabetes drug exenatide (Byetta). Another toxin from Gila monster saliva has been studied for...
    69 KB (6,687 words) - 10:20, 12 October 2024
  • Thumbnail for Rosuvastatin
    Candesartan Dapagliflozin Disufenton sodium Durvalumab Eculizumab Esomeprazole Exenatide FluMist Fulvestrant Gefitinib Glycopyrronium bromide/formoterol Goserelin...
    42 KB (3,486 words) - 00:32, 30 September 2024
  • Thumbnail for Propofol
    Candesartan Dapagliflozin Disufenton sodium Durvalumab Eculizumab Esomeprazole Exenatide FluMist Fulvestrant Gefitinib Glycopyrronium bromide/formoterol Goserelin...
    56 KB (5,566 words) - 04:53, 25 September 2024
  • the risk of thrombosis. It is an antagonist of glycoprotein IIb/IIIa. Exenatide is a 39-amino-acid peptide that is a synthetic version of exendin-4, a...
    11 KB (1,302 words) - 19:09, 20 November 2023
  • version of exendin-4 called exenatide. In 2002, Eli Lilly entered into an alliance with Amylin to further develop exenatide and secure official approval...
    46 KB (4,854 words) - 00:19, 28 October 2024
  • Thumbnail for Metformin
    K+ATP GLP-1 receptor agonists Albiglutide‡ Danuglipron† Dulaglutide Exenatide Liraglutide Lixisenatide Orforglipron§ Semaglutide Taspoglutide† DPP-4...
    151 KB (14,475 words) - 01:04, 25 October 2024
  • Thumbnail for Quetiapine
    Candesartan Dapagliflozin Disufenton sodium Durvalumab Eculizumab Esomeprazole Exenatide FluMist Fulvestrant Gefitinib Glycopyrronium bromide/formoterol Goserelin...
    79 KB (6,427 words) - 19:30, 7 October 2024
  • Thumbnail for Pancreatitis
    pancreatitis including metformin, but glucagon-like peptide-1 mimetics such as exenatide are more strongly associated with pancreatitis by promoting inflammation...
    42 KB (4,144 words) - 00:26, 19 October 2024
  • Thumbnail for Dapagliflozin
    K+ATP GLP-1 receptor agonists Albiglutide‡ Danuglipron† Dulaglutide Exenatide Liraglutide Lixisenatide Orforglipron§ Semaglutide Taspoglutide† DPP-4...
    53 KB (4,975 words) - 03:43, 30 September 2024
  • Thumbnail for Eli Lilly and Company
    insulin product in the U.S., Basaglar (insulin glargine). Lilly brought exenatide to market—the first of the GLP-1 receptor agonists—followed by blockbuster...
    162 KB (14,910 words) - 14:56, 27 October 2024
  • Thumbnail for Retatrutide
    K+ATP GLP-1 receptor agonists Albiglutide‡ Danuglipron† Dulaglutide Exenatide Liraglutide Lixisenatide Orforglipron§ Semaglutide Taspoglutide† DPP-4...
    4 KB (328 words) - 05:24, 6 August 2024
  • Thumbnail for Metoprolol
    Candesartan Dapagliflozin Disufenton sodium Durvalumab Eculizumab Esomeprazole Exenatide FluMist Fulvestrant Gefitinib Glycopyrronium bromide/formoterol Goserelin...
    31 KB (2,632 words) - 22:56, 26 October 2024
  • Thumbnail for AstraZeneca
    Candesartan Dapagliflozin Disufenton sodium Durvalumab Eculizumab Esomeprazole Exenatide FluMist Fulvestrant Gefitinib Glycopyrronium bromide/formoterol Goserelin...
    86 KB (7,963 words) - 18:33, 12 September 2024
  • Thumbnail for Omeprazole
    Candesartan Dapagliflozin Disufenton sodium Durvalumab Eculizumab Esomeprazole Exenatide FluMist Fulvestrant Gefitinib Glycopyrronium bromide/formoterol Goserelin...
    42 KB (3,798 words) - 21:12, 26 October 2024
  • Thumbnail for Orforglipron
    K+ATP GLP-1 receptor agonists Albiglutide‡ Danuglipron† Dulaglutide Exenatide Liraglutide Lixisenatide Orforglipron§ Semaglutide Taspoglutide† DPP-4...
    3 KB (184 words) - 13:53, 14 June 2024
  • Thumbnail for Glucagon-like peptide-1
    peptide-2 Type 2 diabetes GLP-1 receptor agonists : albiglutide, dulaglutide, exenatide, liraglutide, lixisenatide, tirzepatide and semaglutide, the latter of...
    29 KB (3,613 words) - 17:53, 26 October 2024
  • Thumbnail for Incretin
    principally act as agonists of the GLP-1 receptor and are thus insulinotropic. Exenatide was the first drug in this class to be used in the treatment of type 2...
    7 KB (885 words) - 09:29, 30 September 2024
  • Thumbnail for Gliclazide
    K+ATP GLP-1 receptor agonists Albiglutide‡ Danuglipron† Dulaglutide Exenatide Liraglutide Lixisenatide Orforglipron§ Semaglutide Taspoglutide† DPP-4...
    18 KB (1,514 words) - 15:51, 7 June 2024
  • Thumbnail for Isosorbide mononitrate
    Candesartan Dapagliflozin Disufenton sodium Durvalumab Eculizumab Esomeprazole Exenatide FluMist Fulvestrant Gefitinib Glycopyrronium bromide/formoterol Goserelin...
    10 KB (836 words) - 03:56, 30 September 2024
  • S. Food and Drug Administration (FDA) has approved a treatment called Exenatide, based on the saliva of a Gila monster, to control blood sugar in patients...
    101 KB (12,818 words) - 21:41, 12 October 2024
  • Thumbnail for Liraglutide
    with liraglutide 1.8 mg compared to insulin glargine, 0.33% more than exenatide 10 μg twice daily, sitagliptin and rosiglitazone. In a randomized controlled...
    33 KB (2,859 words) - 07:55, 30 September 2024
  • and pH differences. As a consequence, most peptides (such as insulin, exenatide, vasopressin, etc.) or proteins (such as interferon, EPO and interleukins)...
    10 KB (1,210 words) - 12:41, 14 July 2024
  • Thumbnail for Trastuzumab deruxtecan
    Candesartan Dapagliflozin Disufenton sodium Durvalumab Eculizumab Esomeprazole Exenatide FluMist Fulvestrant Gefitinib Glycopyrronium bromide/formoterol Goserelin...
    25 KB (2,086 words) - 02:24, 16 July 2024